Case study 2: new insights: clinical pearls for using incretin mimetics in type 2 diabetes.
作者信息
Peters Anne L, Miller Donna
机构信息
The University of Southern California, Clinical Diabetes Programs, Los Angeles, California (Dr Peters)
The USC Westside Center for Diabetes, Beverly Hills, California (Ms Miller)
出版信息
Diabetes Educ. 2007 Jan-Feb;33 Suppl 1:14S-19S. doi: 10.1177/0145721706298435.
PMID:17272804
Abstract
摘要
相似文献
1
Case study 2: new insights: clinical pearls for using incretin mimetics in type 2 diabetes.
Diabetes Educ. 2007 Jan-Feb;33 Suppl 1:14S-19S. doi: 10.1177/0145721706298435.
2
[Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus].
Vnitr Lek. 2008 Apr;54(4):377-86.
3
[Exenatide convinces in a six-month study: HbA1c sunk significantly].
MMW Fortschr Med. 2009 May 7;151(19):51.
4
[Type 2 diabetic patient with reduced beta-cell function. New substance class: incretin-mimetics].
MMW Fortschr Med. 2005 Aug 4;147(31-32):55.
5
[Therapy with incretin mimetic exenatide. Soon HbA1c value and weight decrease permanently].
MMW Fortschr Med. 2006 Sep 14;148(37):55.
6
Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients.
Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):e61-3. doi: 10.1016/j.clinre.2013.10.013. Epub 2013 Dec 4.
7
Clinical experience with exenatide in a routine secondary care diabetes clinic.
Prim Care Diabetes. 2010 Apr;4(1):57-60. doi: 10.1016/j.pcd.2009.11.001.
8
[Improved blood sugar control plus weight loss].
MMW Fortschr Med. 2006 Aug 17;148(33-34):51.
9
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.
Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1346-53. doi: 10.1016/j.numecd.2014.07.014. Epub 2014 Oct 6.
10
Effect of exenatide on inflammatory and oxidative stress markers in patients with type 2 diabetes mellitus.
Diabetes Technol Ther. 2011 Feb;13(2):143-8. doi: 10.1089/dia.2010.0048.
引用本文的文献
1
Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects.
Diabet Med. 2010 Oct;27(10):1168-73. doi: 10.1111/j.1464-5491.2010.03085.x.
Zotero 插件